Masimo (NASDAQ: MASI), a leading global provider of medical
technology and automation solutions, and UCHealth, a nationally
recognized network of hospitals, clinics, and providers based in
Colorado, announced today that they are entering into a strategic
collaboration to improve the standard of patient care using the
latest in virtual care and telehealth capabilities. With an
emphasis on advancing technology-enabled care, including virtual
and remote care, the collaboration is designed to leverage the
unique capabilities of both organizations and pursue their mutual
goals of improving patient outcomes, reducing the cost of care, and
transforming models of care delivery across the continuum, both in
and outside the hospital.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240220607145/en/
Masimo and UCHealth (Graphic: Business
Wire)
Joe Kiani, Founder and CEO of Masimo, said, “We are grateful for
the opportunity to collaborate with world-class organizations like
UCHealth. By combining our technological expertise and their
clinical expertise, together we can foster a new generation of
healthcare solutions that improve the lives of patients and
clinicians alike – ultimately advancing the forefront of care.”
“UCHealth is committed to driving medical advances through
clinical innovation, pioneering research and world-class education.
Our commitment aligns with Masimo’s vision for achieving tomorrow’s
outcomes and helping institutions like ours improve the ways we
monitor physiological status across more care areas than ever
before, and extend high-quality care beyond the hospital and into
the home by harnessing the power of data science and sensors,” said
Dr. Richard Zane, Chief Innovation Officer at UCHealth and Chair of
Emergency Medicine at the University of Colorado School of
Medicine. “We are particularly excited by Masimo’s innovations in
telehealth, virtual and remote care, and how they can help us
support improved outcomes for our patients and for people
everywhere.”
Opportunities for collaboration between Masimo and UCHealth may
include:
- Offering innovative virtual care and remote monitoring
solutions, through the optimization of enterprise patient
monitoring technologies, patient flow management, and advanced
analytics.
- Augmenting UCHealth’s expertise in evidence-based clinical
workflows with Masimo virtual care solutions.
- Collaborating on innovative direct-to-consumer (D2C) and
provider-to-provider (P2P) services, to introduce virtual clinical
services focusing on episodic and chronic care management.
@Masimo | #Masimo
About Masimo
Masimo (NASDAQ: MASI) is a global medical technology company
that develops and produces a wide array of industry-leading
monitoring technologies, including innovative measurements,
sensors, patient monitors, and automation and connectivity
solutions. In addition, Masimo Consumer Audio is home to eight
legendary audio brands, including Bowers & Wilkins, Denon,
Marantz, and Polk Audio. Our mission is to improve life, improve
patient outcomes, and reduce the cost of care. Masimo SET®
Measure-through Motion and Low Perfusion™ pulse oximetry,
introduced in 1995, has been shown in over 100 independent and
objective studies to outperform other pulse oximetry technologies.1
Masimo SET® has also been shown to help clinicians reduce severe
retinopathy of prematurity in neonates,2 improve CCHD screening in
newborns3 and, when used for continuous monitoring with Masimo
Patient SafetyNet™ in post-surgical wards, reduce rapid response
team activations, ICU transfers, and costs.4-7 Masimo SET® is
estimated to be used on more than 200 million patients in leading
hospitals and other healthcare settings around the world,8 and is
the primary pulse oximetry at 9 of the top 10 hospitals as ranked
in the 2022-23 U.S. News and World Report Best Hospitals Honor
Roll.9 In 2005, Masimo introduced rainbow® Pulse CO-Oximetry
technology, allowing noninvasive and continuous monitoring of blood
constituents that previously could only be measured invasively,
including total hemoglobin (SpHb®), oxygen content (SpOC™),
carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth
Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve
Index (ORi™). In 2013, Masimo introduced the Root® Patient
Monitoring and Connectivity Platform, built from the ground up to
be as flexible and expandable as possible to facilitate the
addition of other Masimo and third-party monitoring technologies;
key Masimo additions include Next Generation SedLine® Brain
Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography
with NomoLine® sampling lines. Masimo’s family of continuous and
spot-check monitoring Pulse CO-Oximeters® includes devices designed
for use in a variety of clinical and non-clinical scenarios,
including tetherless, wearable technology, such as Radius-7®,
Radius PPG®, and Radius VSM™, portable devices like Rad-67®,
fingertip pulse oximeters like MightySat® Rx, and devices available
for use both in the hospital and at home, such as Rad-97® and the
Masimo W1® medical watch. Masimo hospital and home automation and
connectivity solutions are centered around the Masimo Hospital
Automation™ platform, and include Iris® Gateway, iSirona™, Patient
SafetyNet, Replica®, Halo ION®, UniView®, UniView :60™, and Masimo
SafetyNet®. Its growing portfolio of health and wellness solutions
includes Radius Tº®, Masimo W1 Sport, and Masimo Stork™. Additional
information about Masimo and its products may be found at
www.masimo.com. Published clinical studies on Masimo products can
be found at www.masimo.com/evidence/featured-studies/feature/.
RPVi has not received FDA 510(k) clearance and is not available
for sale in the United States. The use of the trademark Patient
SafetyNet is under license from University HealthSystem
Consortium.
References
- Published clinical studies on pulse oximetry and the benefits
of Masimo SET® can be found on our website at
http://www.masimo.com. Comparative studies include independent and
objective studies which are comprised of abstracts presented at
scientific meetings and peer-reviewed journal articles.
- Castillo A et al. Prevention of Retinopathy of Prematurity in
Preterm Infants through Changes in Clinical Practice and SpO2
Technology. Acta Paediatr. 2011 Feb;100(2):188-92.
- de-Wahl Granelli A et al. Impact of pulse oximetry screening on
the detection of duct dependent congenital heart disease: a Swedish
prospective screening study in 39,821 newborns. BMJ. 2009;Jan
8;338.
- Taenzer A et al. Impact of pulse oximetry surveillance on
rescue events and intensive care unit transfers: a before-and-after
concurrence study. Anesthesiology. 2010:112(2):282-287.
- Taenzer A et al. Postoperative Monitoring – The Dartmouth
Experience. Anesthesia Patient Safety Foundation Newsletter.
Spring-Summer 2012.
- McGrath S et al. Surveillance Monitoring Management for General
Care Units: Strategy, Design, and Implementation. The Joint
Commission Journal on Quality and Patient Safety. 2016
Jul;42(7):293-302.
- McGrath S et al. Inpatient Respiratory Arrest Associated With
Sedative and Analgesic Medications: Impact of Continuous Monitoring
on Patient Mortality and Severe Morbidity. J Patient Saf. 2020 14
Mar. DOI: 10.1097/PTS.0000000000000696.
- Estimate: Masimo data on file.
-
http://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview.
Forward-Looking Statements - Masimo
This press release includes forward-looking statements as
defined in Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934, in connection with the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements are based on current expectations about
future events affecting us and are subject to risks and
uncertainties, all of which are difficult to predict and many of
which are beyond our control and could cause our actual results to
differ materially and adversely from those expressed in our
forward-looking statements as a result of various risk factors,
including, but not limited to: risks related to our assumptions
regarding the repeatability of clinical results; risks related to
our belief that Masimo's unique noninvasive measurement
technologies contribute to positive clinical outcomes and patient
safety; risks related to our belief that Masimo noninvasive medical
breakthroughs provide cost-effective solutions and unique
advantages; risks that Masimo may not realize the expected benefits
and goals that may be achieved by its collaboration with UCHealth;
risks that Masimo and UCHealth fail to collaborate in the areas
stated in this press release as planned; risks related to COVID-19;
as well as other factors discussed in the "Risk Factors" section of
our most recent reports filed with the Securities and Exchange
Commission ("SEC"), which may be obtained for free at the SEC's
website at www.sec.gov. Although we believe that the expectations
reflected in our forward-looking statements are reasonable, we do
not know whether our expectations will prove correct. All
forward-looking statements included in this press release are
expressly qualified in their entirety by the foregoing cautionary
statements. You are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of today's date. We
do not undertake any obligation to update, amend or clarify these
statements or the "Risk Factors" contained in our most recent
reports filed with the SEC, whether as a result of new information,
future events or otherwise, except as may be required under the
applicable securities laws.
About UCHealth
UCHealth is an innovative, nonprofit health system that delivers
the highest quality medical care with an excellent patient
experience. UCHealth includes 33,000 employees, 14 acute-care
hospitals and hundreds of physicians across Colorado, southern
Wyoming and western Nebraska. With University of Colorado Hospital
on the CU Anschutz Medical Campus as its academic anchor and the
only adult academic medical center in the region, UCHealth is
dedicated to providing unmatched patient care in the Rocky Mountain
West. Offering more than 200 clinic locations, UCHealth provides
extensive community benefits and pushes the boundaries of medicine
through advanced treatments and clinical trials, improving health
through innovation. UCHealth’s CARE Innovation Center collaborates
with leading industry and start-up partners to fundamentally
transform the way health care is delivered.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240220607145/en/
Media Contacts: Masimo Evan Lamb 949-396-3376
elamb@masimo.com
UCHealth Kelli Christensen 720-848-5809
Kelli.Christensen@uchealth.org
Masimo (NASDAQ:MASI)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Masimo (NASDAQ:MASI)
Historical Stock Chart
Von Mai 2023 bis Mai 2024